Stockreport

InflaRx Reports First Quarter 2022 Financial and Operating Results and Provides Strategic Update

InflaRx N.V.  (IFRX) 
Last inflarx n.v. earnings: 8/14 04:05 pm Check Earnings Report
PDF Quarter highlighted by progress with vilobelimab in several indications: Encouraging Phase III topline results reported in patients with severe COVID-19; discussions [Read more]